Imidazopyridine-Pyrimidine Derivatives, Merck, Apr 15
Summary
The EPO published European patent application EP4003992A1 for 4-(imidazo[1,2-a]pyridin-3-yl)-pyrimidine derivatives filed by Merck Patent GmbH. The A1 publication includes the European search report and designates all contracting states (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR). The IPC classification A61P 35/00 indicates the compounds are directed to anti-cancer therapeutic applications.
About this source
GovPing monitors EPO Patent Bulletin - Therapeutics (A61P) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 24 changes logged to date.
What changed
The EPO published European patent application EP4003992A1 for 4-(imidazo[1,2-a]pyridin-3-yl)-pyrimidine derivatives filed by Merck Patent GmbH. The A1 publication includes the European search report and covers heterocyclic pharmaceutical compositions classified under C07D 471/04 and C07D 487/04, with therapeutic application A61P 35/00 (anti-cancer). The application designates all EPC contracting states.
Competitors developing heterocyclic anti-cancer compounds should review this application to assess potential overlap with their own programmes. Freedom-to-operate analyses may need to account for this publication as it establishes a priority date. Generic manufacturers targeting similar mechanisms should monitor prosecution to understand the scope of claims that may eventually issue.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES
Publication EP4003992A1 Kind: A1 Apr 15, 2026
Applicants
Merck Patent GmbH
Inventors
DORSCH, Dieter, BLUM, Andreas, BUCHSTALLER, Hans-Peter
IPC Classifications
C07D 471/04 20060101AFI20210129BHEP C07D 487/04 20060101ALI20210129BHEP A61K 31/506 20060101ALI20210129BHEP A61P 35/00 20060101ALI20210129BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.